Trials / Completed
CompletedNCT05501613
Early Multimodal Neuromonitoring For Spontaneous Intracerebral Hemorrhage (ICH)
Early Multimodal Neuromonitoring Parameters as Prognostic Factors For Critically Ill Spontaneous ICH Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 65 (actual)
- Sponsor
- Universidade do Porto · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators intend to assess the predictive value of early (first 48 hours) multimodal neuromonitoring parameters concerning late survival in critically ill intracerebral hemorrhage (ICH) patients.
Detailed description
Retrospective observational study based on analyzing the first 48 hours of the multimodal neuromonitoring signal, from spontaneous ICH patients, whose treatment includes invasive intraparenchymal neuromonitoring, treated from January 2015 to September 2021 in a tertiary hospital.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Multimodal Neuromonitoring | Invasive Multimodal Neuromonitoring |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2022-10-01
- Completion
- 2023-02-01
- First posted
- 2022-08-15
- Last updated
- 2023-02-06
Locations
1 site across 1 country: Portugal
Source: ClinicalTrials.gov record NCT05501613. Inclusion in this directory is not an endorsement.